← Eichor
Study identifier: NCT07141082 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Expressive Art Therapy for Elder Adults With Chronic Low Back Pain

Condition: Chronic Low Back Pain  ·  Sponsor: The Hong Kong Polytechnic University

PhaseNA
Planned participants30
Who can joinAll sexes, 60 Years to no upper limit
Healthy volunteersNo

About this study

This research project aims to assess the feasibility of expressive art therapy for elderly adults with chronic low back pain and to evaluate the preliminary efficacy of combining art therapy with exercise intervention. Additionally, the study will investigate facilitators and barriers to participation. A mixed-methods approach will be employed, including a quantitative questionnaire and qualitative semi-structured focus group discussions. The questionnaire will examine physical, functional, and psychological changes potentially influenced by art therapy, while the focus groups will provide in-depth insights into participants' experiences and perceptions of the combined intervention.

This description comes directly from the study's public registry record.

Talk to the study team

Fadi Al Zoubi, PhD  ·  852-2766-6705  ·  fadi.alzoubi@polyu.edu.hk

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Rehabilitation Sciences, The Hong Kong Polytechnic UniversityHong Kong, Hong KongRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07141082